TCIM
GMED icon

TIAA CREF Investment Management’s Globus Medical GMED Stock Holding History

TIAA CREF Investment Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$7.61M Sell
153,999
-4,031
-3% -$182K 0.01% 1191
2018
Q4 		$6.84M Buy
158,030
+12,730
+9% +$635K 0.01% 1170
2018
Q3 		$8.25M Sell
145,300
-167,441
-54% -$8.81M 0.01% 1226
2018
Q2 		$15.8M Buy
312,741
+20,208
+7% +$1.05M 0.01% 872
2018
Q1 		$14.6M Buy
292,533
+26,788
+10% +$1.26M 0.01% 910
2017
Q4 		$10.9M Buy
265,745
+78,678
+42% +$2.75M 0.01% 1090
2017
Q3 		$5.56M Sell
187,067
-4,184
-2% -$128K ﹤0.01% 1552
2017
Q2 		$6.34M Buy
191,251
+1,322
+0.7% +$41.5K ﹤0.01% 1439
2017
Q1 		$5.63M Sell
189,929
-9,088
-5% -$248K ﹤0.01% 1522
2016
Q4 		$4.94M Sell
199,017
-15,169
-7% -$345K ﹤0.01% 1616
2016
Q3 		$4.83K Sell
214,186
-1,672
-0.8% -$39.3K ﹤0.01% 1633
2016
Q2 		$5.14M Buy
215,858
+1,028
+0.5% +$24.7K ﹤0.01% 1519
2016
Q1 		$5.1M Sell
214,830
-3,692
-2% -$90.3K ﹤0.01% 1498
2015
Q4 		$6.08M Sell
218,522
-4,982
-2% -$125K ﹤0.01% 1418
2015
Q3 		$4.62M Sell
223,504
-53,875
-19% -$1.36M ﹤0.01% 1584
2015
Q2 		$7.12M Sell
277,379
-24,737
-8% -$626K 0.01% 1407
2015
Q1 		$7.63M Sell
302,116
-59,623
-16% -$1.45M 0.01% 1344
2014
Q4 		$8.6M Sell
361,739
-14,952
-4% -$331K 0.01% 1229
2014
Q3 		$7.41M Buy
376,691
+8,990
+2% +$185K 0.01% 1316
2014
Q2 		$8.79M Buy
367,701
+140,900
+62% +$3.4M 0.01% 1259
2014
Q1 		$6.03M Buy
226,801
+12,827
+6% +$305K ﹤0.01% 1478
2013
Q4 		$4.32M Sell
213,974
-5,258
-2% -$97.6K ﹤0.01% 1739
2013
Q3 		$3.83M Sell
219,232
-2,225
-1% -$38.5K ﹤0.01% 1783
2013
Q2 		$3.73M Buy
+221,457
New +$3.42M ﹤0.01% 1744

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

TIAA CREF Investment Management's GMED Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Globus Medical (GMED) stake by 2.6% in Q1 2019, selling an estimated $182K and leaving 153,999 shares worth $7.61M. The position accounts for 0.01% of the portfolio, ranked #1191.

TIAA CREF Investment Management first reported a position in GMED in Q2 2013 and has held it in 24 quarters since. The position peaked at $15.8M in Q2 2018. 269 funds tracked by Wall St. Rank hold GMED as of Q1 2019.

  • TIAA CREF Investment Management held 153,999 shares of Globus Medical worth $7.61M as of Q1 2019.
  • TIAA CREF Investment Management sold 4,031 Globus Medical shares in Q1 2019, an estimated $182K.
  • Globus Medical made up 0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1191 holding.
  • TIAA CREF Investment Management first reported a position in Globus Medical in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Globus Medical position peaked at $15.8M in Q2 2018.
  • 269 funds tracked by Wall St. Rank held Globus Medical as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.